Printer Friendly
The Free Library
19,122,084 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Direct Music Group, Inc Announces Acquisition of Cell Bio-Systems, Inc. and Name Change.


Business Editors/Health/Medical Writers

SAN DIEGO--(BUSINESS WIRE)--April 8, 2004

Direct Music Group, Inc (Pink Sheets:DMGR) announced that it has acquired 100% of the share capital of Cell Bio-Systems, Inc, Delaware. The Company, which has been renamed Cell Bio-Systems, Inc. is also currently in the process of obtaining a new trading symbol Trading symbol

See: Ticker symbol
.

All previous board members and management have resigned. The current Board consists of Marc Pilkington, President and Director, and J. Harlow Wright, Chief Financial Officer, Secretary and Director.

The reverse merger resulted in the former Direct Music Group, Inc., in exchange for 100 percent of the share capital of Cell Bio-Systems, Inc, issuing to Cell Bio-Systems, Inc. shareholders 51,891,724 restricted common shares.

About Cell Bio-Systems, Inc:

Cell Bio-Systems, Inc., a Nevada Corporation, through its wholly owned subsidiary Wholly Owned Subsidiary

A subsidiary whose parent company owns 100% of its common stock.

Notes:
In other words, the parent company owns the company outright and there are no minority owners.
 Cell Bio-Systems Inc Delaware, is a Medical Device Biotechnology Company seeking to manufacture and distribute patented technologies for Plastic and Cosmetic Surgery cosmetic surgery, plastic surgery for cosmetic purposes, such as the improvement of the appearance of the face by removing wrinkles or reshaping the nose. , Biopsy, Orthopedic Surgery Orthopedic Surgery Definition

Orthopedic (sometimes spelled orthopaedic) surgery is surgery performed by a medical specialist, such as an orthopedist or orthopedic surgeon, trained to deal with problems that develop in the bones, joints, and ligaments
 and other Living Tissue Markets. Cell Bio-Systems has licensed patented and proprietary technology designed to secure connections in a closed system and increase living tissue survivability sur·viv·a·ble  
adj.
1. Capable of surviving: survivable organisms in a hostile environment.

2. That can be survived: a survivable, but very serious, illness.
 by changing the surfaces in which live tissue at a cellular level comes in contact with during a procedure. Every surface the live tissue contacts during its journey from source to destination must be at a minimum neutral if not positive to cell viability. Current instrumentation is damaging to live tissue. This is a critical element in determining a successful, low risk, predictable outcome. To answer this, Cell Bio-Systems has developed the Living Tissue Management System(TM) (LTMS LTMS Laugh to Myself ). LTMS is more than individual instruments; it is a concept of manipulating live tissue outside of the source (body) while achieving minimum damage at a cellular level in order to achieve a safe and successful outcome. The core product in this system is the LTMS Cannula cannula /can·nu·la/ (kan´u-lah) a tube for insertion into a vessel, duct, or cavity; during insertion its lumen is usually occupied by a trocar.

can·nu·la or can·u·la
n. pl.
. This front line device is used directly in the tissue source to both begin and or end the process of live tissue management. All of the other products and devices which have the sole purpose of supporting the LTMS Cannula will be part of LTMS products and devices.
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Apr 8, 2004
Words:357
Previous Article:CSC Holdings, Inc. Gives Notice of Redemption of Its Series H and Series M Preferred Stock and Its 9 7/8% Senior Subordinated Debentures.
Next Article:AirGate PCS, Inc. Company Expands Board and Appoints Three New Independent Directors; Company Holds Annual Meeting of Shareowners.



Related Articles
PerSeptive Biosystems, Inc. Redeems Preferred Stock Held by Millipore Corporation for Common Stock at $11 per Share.
PE Corporation to Change Name to Applera Corporation; PE Biosystems Group Name Also to Change to Applied Biosystems Group and NYSE Stock Symbol to...
Tech Science Press launches two new journals.
Applied Biosystems Obtains Injunctions in Germany Against Bio-Rad and MJ Research.
Applied Biosystems/MDS SCIEX and BIOCRATES Announce Metabolomics Collaboration.
Invitrogen Corporation Expands Proteomics Capabilities with Launch of Mass Spectrometry Solutions and Co-Marketing Agreement with Applied Biosystems.
Applied Biosystems Obtains a Permanent Injunction Against MJ Research in the U.S.; Bio-Rad and MJ Research Permanently Enjoined from Making or...
Applied Biosystems Reports Fiscal 2006 Third Quarter Results.
Tasco Holdings International Changes Name to Bio-Matrix Scientific Group Inc. Effective September 5, 2006; New Symbol is BMSN on the Bulletin Board.
Rapid genome sequencing of RNA viruses.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles